NCT02484729View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males

PHASE1CompletedINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

SafetyTolerabilityPharmacokineticsHealthy Subjects

Interventions

DRUG

AZD9977, oral suspension

Single ascending doses of AZD9977 oral suspension (Part A) Single dose of AZD9977 oral suspension in IntelliCap® capsule in regional absorption part (Part B)

DRUG

Placebo, oral suspension

Matching placebo

DRUG

AZD9977, oral solution

AZD9977, single dose of oral solution in Part B as reference

Trial Locations (1)

Unknown

Research Site, Harrow